###begin article-title 0
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Wnt1 is epistatic to Id2 in inducing mammary hyperplasia, ductal side-branching, and tumors in the mouse
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
During pregnancy, the mammary glands from Id2 mutant animals are deficient in lobulo-alveolar development. This failure of development is believed to be due to a proliferation defect.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
We have asked whether functional Id2 expression is necessary for Wnt induced mammary hyperplasia, side branching, and cancer, by generating mice expressing a Wnt1 transgene in an Id2 mutant background.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 150 153 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
We show in this work that forced expression of Wnt1 in the mammary gland is capable of overcoming the block to proliferation caused by the absence of Id2. We also show that Wnt1 expression is able to cause mammary tumors in an Id2 mutant background.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
We conclude that functional Id2 expression is not required for Wnt1 to induce mammary hyperplasia and mammary tumors.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
Basic helix-loop-helix (bHLH) transcription factors such as MyoD, E12, and E47 are key regulators of gene expression and control many differentiation events during development [1-3]. These transcription factors bind E-box or E-box-like sequences as homo-or heterodimers, and control the transcription of target genes containing these sequences in their promoters. The HLH domains dimerize with each other, whereas the basic domains bind to DNA. The Id (Inhibitor of DNA binding) proteins are HLH proteins that lack a basic domain. Id proteins act as dominant inhibitors of bHLH transcription factors by blocking their ability to bind to DNA and activate gene transcription [2,3]. Since the bHLH proteins regulate cell-type specific gene expression during cell commitment and differentiation, the formation of inactive heterodimers of bHLH proteins with Id proteins inhibits the commitment and differentiation the bHLH proteins promote.
###end p 11
###begin p 12
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
###xml 310 314 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 464 468 464 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 512 513 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 514 515 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 653 657 650 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 739 743 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 884 888 881 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
There are 4 mammalian Id genes, which show differences in their patterns of expression and function [2,3]. One of them, Id2, is expressed in glandular and ductal epithelium of the mouse mammary gland and has also been implicated in its development. Mammary glands of female mice that are homozygous mutant for Id2 have impaired lobulo-alveolar development [4]. In several tissues, including colon tumors induced by activation of the Wnt pathway, the expression of Id2 is regulated by Wnt-beta catenin signaling [5,6]. It has been proposed that Wnt signaling may inhibit differentiation and promote the maintenance of a proliferative state by increasing Id2 expression, thereby leading to cancer. We have asked therefore whether functional Id2 expression is necessary for Wnt induced mammary hyperplasia, side branching and cancer, by generating mice expressing a Wnt1 transgene in an Id2 mutant background.
###end p 12
###begin title 13
Methods
###end title 13
###begin p 14
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
We used heterozygous Id2 males and females on a 129/Sv background. Id2 genotyping was done by PCR (95C, 5 min; 62C, 1 min, 72C, 1 min, 95C,1 min, 30 cycles; 62C, 1 min, 72C, 5 min) using primers Id2-S (5'-tctgagcttatgtcgaatgatagc-3'), Id-2AS (5'-cgtgttctcctggtgaaatggctg-3'), and neo 1 (5'-tcgtgctttacggtatcgccgctc-3").
###end p 14
###begin p 15
###xml 22 26 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 276 280 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 354 369 <span type="species:ncbi:10090">transgenic mice</span>
Hemizygous transgenic MMTV-Wnt1 males on a mixed FVB/BL6/SJL background were obtained from Yi Li in the H.Varmus laboratory. Genotyping was done by PCR (94C, 4 min; 94C, 45 sec, 55C, 30 sec, 72C, 60 sec, 30 cycles; 72C, 10 min) using Wnt1 (5'-gaacttgcttctcttctcatagcc-3') and SV40 (5'-ccacacaggcatagagtgtctgc-3') primers that produce a 350 bp product in transgenic mice.
###end p 15
###begin title 16
Carmine staining
###end title 16
###begin p 17
###xml 332 333 332 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Five mammary glands per mouse were removed and fat and muscle were dissected away. The glands were flattened between two slides and flooded with Carnoy's fixative (3:1 95% ethanol to glacial acetic acid) and fixed overnight. They were then de-fatted in 3 changes of acetone, rehydrated, stained overnight in 0.2% carmine and 0.5%KSO4, dehydrated, cleared in xylene, and mounted in Permount.
###end p 17
###begin title 18
Results
###end title 18
###begin p 19
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 586 590 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 610 614 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 637 640 637 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 692 696 692 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 725 726 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 92 97 <span type="species:ncbi:10090">Mouse</span>
###xml 119 123 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 411 415 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 595 599 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 623 627 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
We used mice carrying a transgene in which Wnt1 is under the control of the promoter of the Mouse Mammary Tumor Virus (MMTV-Wnt1 Tg) [7] and we crossed these to Id2 loss of function mutant mice [4,8]. Crosses were set up to avoid reliance on Id2 -/- or Wnt1 transgenic mothers, as these animals cannot feed their young [4,7]. Id2 +/- females were crossed with MMTV-Wnt1 hemizygous transgenic males, producing 7 MMTV-Wnt1 Tg; Id2+/- males (Figure 1). These males were then crossed with Id2 +/- females to produce the experimental and control classes of virgin female mice: MMTV-Wnt1 Tg; Id2 -/-, MMTV-Wnt1 Tg ; Id2 +/-, and MMTV-Wnt1 Tg; Id2, as well as smaller numbers of animals in Id2 -/-; Id2 +/-; and WT classes. (Figure 1)
###end p 19
###begin p 20
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
The subject animals were kept in mixed groups in autoclaved cages because Id2 -/- mice have an immunologic defect. Even with this care, 50% die before maturity [8]. Id2 -/- mice were born in sub-Mendelian ratios, they were smaller than litter-mates, and several died of unknown causes.
###end p 20
###begin p 21
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 389 393 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 480 484 480 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 507 511 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 604 605 604 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 797 800 797 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
###xml 808 811 808 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
###xml 1026 1030 1026 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 465 469 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 492 496 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 764 768 <span type="species:ncbi:10090">mice</span>
We examined the morphology of the mammary gland. At 3, 4.5, and 6 months the ductal branching patterns in normal mammary glands of 24 virgin mice from all six classes were examined in carmine stained whole mounts (Figure 2). As has been previously observed by others, the MMTV-Wnt1 Tg female glands had excessive ductal side branching compared to those of WT females [7] while Id2 +/- and Id2 -/- females glands were similar to those of WT females [4]. Glands from MMTV-Wnt1 Tg ; Id2 +/- and MMTV-Wnt1 Tg ; Id2 -/- mice had branching patterns resembling those of MMTV-Wnt1 Tg females at 3 months (Figure 2). At six months the three classes of transgenic mammary glands had very extensive, dense hyperplasia and side branching resembling that of pregnant wild type mice, while the six month virgin Id2+/- and Id2-/- glands had no additional branching and the six month virgin WT glands had moderate additional branching. Therefore, it appears that forced expression of Wnt1 in virgin mammary glands can overcome the absence of Id2 and lead to a highly branched ductal tree resembling the tree achieved normally during pregnancy.
###end p 21
###begin p 22
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 386 390 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 413 417 413 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 69 73 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 205 209 <span type="species:ncbi:10090">Mice</span>
###xml 371 375 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 398 402 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
In parallel, we examined tumor incidence in the animals. We excluded MMTV-Wnt1 Tg ; Id2 -/- females that died without developing tumors before 34 weeks, our endpoint, leaving only 8 animals in this group. Mice were examined and palpated weekly for mammary tumors. The smallest tumors detected using this method were 0.5 cm in diameter, but could be as large as 2 cm. The MMTV-Wnt1 Tg ; Id2 +/+ and MMTV-Wnt1 Tg ; Id2 +/- cohorts consisted of 21 and 23 females respectively. All three cohorts showed a similar rate of tumorigenesis (Figure 3). We concluded that Wnt1 is epistatic to Id2 in tumorigenesis, just as it is in promoting hyperplasia and side branching of the mammary gland (Figure 2).
###end p 22
###begin title 23
Discussion
###end title 23
###begin p 24
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 716 720 716 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
The lack of Id2, a Wnt target, has severe consequences for mouse mammary gland development. During pregnancy, the Id2 mammary gland is deficient in lobulo-alveolar development. This failure of development is believed to be due to a proliferation failure rather than precocious differentiation of the mammary epithelia [4]. We show in this work that forced expression of Wnt1 in the mammary gland is capable of overcoming this block to proliferation. Although many targets of the Wnt pathway have been identified (see ), the mechanism through which hyperplasia and side branching is promoted by Wnt1 expression in the virgin mammary gland is unknown. Our results demonstrate that Wnt1 is not operating solely through Id2 or that it is not operating through Id2 at all.
###end p 24
###begin p 25
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 530 533 530 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 617 620 617 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
###xml 703 707 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
Another known Wnt target with a similar loss of function phenotype is Cyclin D1 [9], a protein whose expression promotes advancement through the cell cycle and whose over expression results in hyperplasia and tumors in the mammary gland [10]. However, when Wnt1 is expressed in Cyclin D1 -/- mice, only a slight reduction in tumorigenesis is observed [11], suggesting that the Wnt1 pathway also does not operate primarily through Cyclin D1. Furthermore, over expression of Cyclin D1 did not promote lobulo-alveolar development in Id2-/- mice [12], a result that is in contrast to the dense side branching of the Wnt1 Id2-/- phenotype, suggesting that Wnt1 signaling is independent of both Cyclin D1 and Id2 in the mammary gland.
###end p 25
###begin title 26
Conclusions
###end title 26
###begin p 27
###xml 140 143 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
By showing that forced expression of Wnt1 in the mammary gland is capable of overcoming the block to proliferation caused by the absence of Id2, we conclude that functional Id2 expression is not required for Wnt1 to induce mammary hyperplasia and mammary tumors.
###end p 27
###begin title 28
Competing interests
###end title 28
###begin p 29
The author(s) declare that they have no competing interests.
###end p 29
###begin title 30
Author's contributions
###end title 30
###begin p 31
SM and CR carried out the experiments. YY participated in the design of the study. SM and RN conceived of the study, participated in its design and coordination and wrote the manuscript. All authors read and approved the final manuscript.
###end p 31
###begin title 32
Pre-publication history
###end title 32
###begin p 33
The pre-publication history for this paper can be accessed here:
###end p 33
###begin p 34

###end p 34
###begin title 35
Acknowledgements
###end title 35
###begin p 36
The work was supported by the Howard Hughes Medical Institute and a grant from the US ARMY Medical Research and Material Command (DAMD17-99-1-9386).
###end p 36
###begin article-title 37
The Myc/Max/Mad network and the transcriptional control of cell behavior
###end article-title 37
###begin article-title 38
Id helix-loop-helix proteins in cell growth and differentiation
###end article-title 38
###begin article-title 39
The helix-loop-helix inhibitor Id2 and cell differentiation control
###end article-title 39
###begin article-title 40
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Lactation defect in mice lacking the helix-loop-helix inhibitor Id2.
###end article-title 40
###begin article-title 41
###xml 45 50 <span type="species:ncbi:9606">human</span>
A transcriptional response to Wnt protein in human embryonic carcinoma cells
###end article-title 41
###begin article-title 42
Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma
###end article-title 42
###begin article-title 43
###xml 32 47 <span type="species:ncbi:10090">transgenic mice</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice
###end article-title 43
###begin article-title 44
Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2
###end article-title 44
###begin article-title 45
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
###end article-title 45
###begin article-title 46
###xml 37 41 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 52 67 <span type="species:ncbi:10090">transgenic mice</span>
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
###end article-title 46
###begin article-title 47
Specific protection against breast cancers by cyclin D1 ablation
###end article-title 47
###begin article-title 48
Forced expression of cyclin D1 does not compensate for Id2 deficiency in the mammary gland
###end article-title 48
###begin title 49
Figures and Tables
###end title 49
###begin p 50
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
The Wnt1 transgene was crossed into an Id2 -/- background in order to produce cohorts of WT, Id2 +/-, and Id2 -/- females with and without the Wnt1 transgene. The scheme was designed so that mothers could feed their own young and so that all cohorts being compared would share a common background.
###end p 50
###begin p 51
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 193 196 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
###xml 358 361 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2</italic>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 312 316 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
Carmine stained mammary gland whole mounts were made from virgin females. Top row, left to right: normal mammary gland development was observed in wild type (13 weeks), Id2 +/- (26 weeks), and Id2-/- (26 weeks) animals. Bottom row, left to right: Wnt1 induced hyperplasia and side branching were forced when the MMTV-Wnt1 transgene was present in wild type, Id2+/-, and Id2 -/- animals (all 19 weeks). Branching patterns are representative of a consistent phenotype observed in all mice and in both tumor-free glands and in glandular tissue associated with tumors in the MMTV-Wnt1 mice.
###end p 51
###begin p 52
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id2 </italic>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 23 27 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 46 50 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 82 86 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 219 223 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 242 246 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 275 279 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Three cohorts of mice, MMTV-Wnt1 Tg (n = 21), MMTV-Wnt1 Tg; Id2 +/- (n = 23), and MMTV-Wnt1 Tg; Id2 -/- (n = 8) were examined weekly by visual examination and palpation. No differences in tumor incidence were observed. MMTV-Wnt1 Tg : square; MMTV-Wnt1 Tg; Id2 +/- : diamond; MMTV-Wnt1 Tg; Id2 -/-: triangle.
###end p 52

